Download - CHF/CCM board review
-
8/10/2019 CHF/CCM board review
1/46
!"#$%&'(% *%+,- .+/01,%
!"#$ &'()*+, -./.
/*0*1*'" '2 !30+"453 65+)7 /*15+15
8)*9(+: +"3 ;':5"
-
8/10/2019 CHF/CCM board review
2/46
2/&30"&1,%
? (+05 "' )5>+@'"1(*=1 7' 3*14>'15
-
8/10/2019 CHF/CCM board review
3/46
456%3'(%&
!7 7(5 5"3 '2 7(*1 4'$)15, A'$ B*>> C5 +C>5 7'D
/514)*C5 7(5 5=*35:*'>'9A +"3 =+7('=(A1*'>'9A '2
6E
/*+9"'15 +4$75 354':=5"1+753 6E F!/6EGD
H>*"*4+> 5I+:
&+7)*$)5@4 =5=@351
J$>:'"+)A +)75)A 4+7(575)*K+@'"
-+"+95 !/6ED
J(+):+4'>'9*4 7)5+7:5"7
H+)3*')5"+> 1A"3)':5
&'"L3$)+C>5 :54(+"*4+> 1$==')7
-
8/10/2019 CHF/CCM board review
4/46
2%7#/'"# "8 *%+,- .+/01,%
! #$% &'()*+,- .$%- ($% $%*/( '& '-0*1*23% ,4
5*'-(*'-'-6 * 0*/7'*0 ,)(1)( *7%8)*(% (,
*00,55,7*(% 5%(*2,3'0 /%8)'/%5%-(& *-7 ($%
9%-,)& /%()/-:;
-
8/10/2019 CHF/CCM board review
5/46
*%+,- .+/01,%9 :;% >*'" !:5)*4+"1ONPQ,QQQ "5B 4+151RA)
SQT 35+3 B*7(*" S A)1 '2 3*+9"'1*1OSN,UVQ 35+7(1RA)
65+>7(4+)5 8$)35"
W.W :*>>*'" ('1=*7+>*K+@'"1RA)O:'17 2)5X$5"7 4+$15 '2
('1=*7+>*K+@'" *" =+@5"71 Y NS A)1
UVT ('1=*7+>*K53 +7 >5+17 '"45 +Z5) 3*+9"'1*1
!Z5) ('1=*7+>*K+@'", VQT W A5+) :')7+>*7A
[QT )5L+3:*11*'" )+75 B*7(*" VQ 3+A1, SQT \ N :7(1
]V^.[ C*>>*'" FWL[T 7'7+> (5+>7(4+)5 4'17G!6! M7+@1@41. H*)4$>+@'" [QW[_W[SD5[L[[Q.
-
8/10/2019 CHF/CCM board review
6/46
>'"0"$? "8 *%+,- .+/01,%
`@'>'9A T
H!/ SQ.V
&'" H!/ a^.P
&' 4+$15 9*05" WV.V
H+$15 9*05" VN.a
?3*'=+7(*4 WU.[
b+>0$>+) a.Q
6c& V.U
!>4'('> W.U
b*)+> Q.a
J'17=+)7$: Q.a
!:A>'*3 Q.W
de7(5)f P.N
e7(5) 4+$151 7' 4'"1*35)
g5"5@4
H'"95"*7+> (5+)7 3*15+15
H'4+*"5
H(5:'7(5)+=ARhic
H(+9+1
6?b
c(A)'*3
J(5'4()':'4A7':+
M+)4'*3
65:'4()':+7'1*1
j"4'"7)'>>53 7+4(A4+)3*+ F!kCG
!3+=753 2)': i53k5>3, -+A' H>*"
-
8/10/2019 CHF/CCM board review
7/46
@+-;"A;?&/"0"$? "8 *%+,- .+/01,%
B%C D%#-,/310+, 2?&81#3'"#
H')'"+)A /*15+15 H+)3*':A'=+7(A H+)3*+4 e05)>'+3
D+&"3"#&-,/3'"# e)9+" 8>''3l'B H+)3*+4 i5:'35>*"9
!Mm5>57+>
C>''3l'B
!i8E, &+
)575"@'"
nb
/*>+7+@'"
nb
6A=5)7)'=(A
MA:=7':1, E>$*3 )575"@'", /5+7(
!))(A7(:*+1
-
8/10/2019 CHF/CCM board review
8/46
EF40-50%
EF!5
0%
EF"4
0%
E'"+)'B g, 57 +>. o!HH [QQP_ SQDPNULPP
2/&-,/51'"# "8 >. /# @+'%#-& *"&A/-+0/F%G
H/-; *.
*.I@>. (&J *.,>.
e>35)
E5:+>5
6c&
Hp/
!H!/
-
8/10/2019 CHF/CCM board review
9/46
KLMK A-& H/-; !*.N >. +&&%&&=%#- 4#-+,/" @,"(/#3% OPPPIKMMO
Q",-+0/-?N >.RSMT (&J >.UVMT WM G+?& XT (&J VT YAZMJML[
O ?%+, K\T (&J KKT YAZMJMX[
]1,(/(+0 EC%, *"&A/-+0/F+'"# 8", *.
8(+@+, 57 +>. &`o- [QQN_ VSSD[NQL^
-
8/10/2019 CHF/CCM board review
10/46
!;,"#/3 *. Q+#+$%=%#- ^+&%G "# E!!_
E*E !0+&&/73+'"#
]:E`> E!7 (*9( )*1m 2')
6E C$7 B*7('$7
17)$47$)+> (5+)7
3*15+15 ')
1A:=7':1 '2 6E
]:E`> ^M7)$47$)+> (5+)7
3*15+15 B*7('$7
4$))5"7 ') =)*')
1*9"1 ')
1A:=7':1 '2 6E
]:E`> !M7)$47$)+> (5+)7
3*15+15 B*7(
=)*') ') 4$))5"7
1A:=7':1 '2 6E
]:E`> 2i52)+47')A 6E
)5X$*)*"9
1=54*+>*K53
*"75)05"@'"1
6$"7 57 +>. !"#$%&'()*[QQS_WW[DWU[SLS[.
L c)5+7$"35)>A*"9
)*1m 2+47')1
L
!H`L?
LqL8>'4m5)
L!i8 *2
!H`L?
*"7'>5)+"7
L
!H`L?
L
qLC>'4m5)
L
/*$)5@41 2') 1I1
a# &%0%3-%G A-&9
L
M=*)'"'>+47'"5
L
/*9'I*"L!i8
L6A3)+>R"*7)+751
LHic
L ?H/
L J+>>*+@05 4+)5
L ?"'7)'=51
L
c)+"1=>+"7
L -HM
L
`I=5)*:5"7+> iI
-
8/10/2019 CHF/CCM board review
11/46
!. !7 )*1m =+@5"71 B*7('$717)$47$)+> (5+)7 3*15+15
8. M7)$47$)+> (5+)7 3*15+15
B*7('$7 1A:=7':1
H. M7)$47$)+> (5+)7 3*15+15 B*7(
=)*') ') 4$))5"7 1A:=7':1
/. i52)+47')A (5+)7 2+*>$)5
?. H+)3*+4 3*15+15 B*7('$7
2$"4@'"+> >*:*7+@'"
??. M>*9(7 >*:*7+@'" '2 =(A1*4+>
+4@0*7A
???. -+)m53 >*:*7+@'" '2 =(A1*4+>
+4@0*7A
?b. ?"+C*>*7A 7' 4+))A '" =(A1*4+>
+4@0*7A B*7('$7 3*14':2')7
E!!_E*E !0+&&/73+'"#
-
8/10/2019 CHF/CCM board review
12/46
E2*. /& + !0/#/3+0 2/+$#"&/&
>?@A
-
8/10/2019 CHF/CCM board review
13/46
^. !: 65+)7 o [QQS_Wa^DPaa.
@-& A,%&%#'#$ -" >c H/-; G?&A#%+
^
-
8/10/2019 CHF/CCM board review
14/46
2/+$#"&'3 B/=/-+'"#& "8 .t B%(%0& =+? 5% %0%(+-%G %(%# /# 3"=A%#&+-%G 3;,"#/3
*.
t
B/=/-%G /#3,%=%#-+0 5%#%7- "(%, 30/#/3+0 +&&%&&=%#-
Q%+&1,%=%#- "8 ^. 65+)7 [QQV_ -4H$>>'$9( 57 +>., !op/ [QQV_ ;+"9 57
+>., H*)4$>+@'" [QQa_ o+"$KK* 57 +>. !: o H+)3*'> [QQS_ -+*15> 57 +>., &`o- [QQ[_ ;$ 57 +>. `$) o
65+)7 E+*>$)5 [QQV_ M(+( 57 +>. o H+)3 E+*> [QWW.
-
8/10/2019 CHF/CCM board review
15/46
4-;%, :%&-& -" 2/+$#"&% E2*.
HhiD
4+)3*':59+>A, *"4)5+153 *"75)1@@+> :+)m*"91, p5)>5AL8
>*"51, 5u$1*'"1
`4('D
nb`E, nb`//, -i, ci
?bH 3*+:575) Y [ 4:, 4'>>+=15 B*7( 1"*u v SQT w x HbJ
n$"9 $>7)+1'$"3D H':571
J$>:'"+)A +)75)A 4+7(575)*K+@'" i'$@"5 $15 "'7 )54'::5"353
j152$> *" 45)7+*" 1*7$+@'"1
-
8/10/2019 CHF/CCM board review
16/46
a& -;%,% &'00 + ,"0% 8", -;% @E
!+-;%-%,e
ESCAPE Investigators, JAMA 2005; 294: 1625
-
8/10/2019 CHF/CCM board review
17/46
c;%# -" 3"#&/G%, @E !+-;%-%,e
M505)5 4>*"*4+> 354':=5"1+@'" B*7( $"45)7+*"(5:'3A"+:*4 =)'k>5 CA C531*35 50+>$+@'"
6A='75"1*'" ') B')15"*"9 )5"+> 2$"4@'" B*7(
5:=*)*4 7(5)+=A
J)51$:53 4+)3*'95"*4 1('4m
!==+)5"7 *"'7)'=5 35=5"35"45 ') )52)+47')A
1A:=7':1
`0+>$+@'" 2') b!/ ') 7)+"1=>+"7 4+"3*3+4A
`0+>$+@'" '2 =$>:'"+)A +)75)*+> (A=5)75"1*'"
-
8/10/2019 CHF/CCM board review
18/46
:,%+-=%#- `"+0& "8 E2*.
!33)511 =)54*=*7+@"9
2+47')1 ?:=)'05 1I1 +"3 5"3L
')9+" =5)2$1*'"
?"*@+75 iI 7' =)505"7 3K=)'9)511*'"R:')7+>*7A
i53$45 neM +"3 )5L
('1=*7+>*K+@'"
89:*(;< "*$"(*= ;'$>)#
'*9 >#:'>
.)?:# @!A@
8*$#:'B: !C
CD(E"F: )#'& #:="E:* G'*'=: #:&'>:9 #"BHB
1I!J/ KLM5
@> :9%$'()*
.)*=">%9"*'& 9F
E'*'=:E:*> D#)=#'EB
-
8/10/2019 CHF/CCM board review
19/46
@,%3/A/-+'#$ .+3-",&
!4$75 4')'"+)A 1A"3)':51R4')'"+)A *14(5:*+
M505)5 (A=5)75"1*'"
!7)*+> ') 05"7)*4$>+) +))(A7(:*+1
?"254@'"
J$>:'"+)A 5:C'>*
i5"+> 2+*>$)5
-53*4+@'"1 F5.9. &M!?/1, 175)'*31, cy/1, nL7A=5 HH81G
&'"+3(5)5"45 F59. 1'3*$: +"3 l$*3 )517)*4@'", :53*4+@'"1G
e7(5) 4+)3*+4 3K F+4$75 5"3'4+)3*@1, +4$75 3*1154@'", +4$75:A'=5)*4+)3*@1G
-
8/10/2019 CHF/CCM board review
20/46
f+'"#+0%I !*. :;%,+A/%&BD 2?&81#3'"#
M+>7R6[e i575"@'"
zH+)3*+4 e$7=$7
b+1'4'"17)*4@'"
!Z5)>'+3J)5>'+3
i!!MRM&M !4@0+@'"
!H` ?"(*C*7')1!i8
!>3'175)'"5 8>'4m5)1
857+ C>'4m5)1
zM+>7R0'>$:5/*$)5@41
b5"'3*>+7')1 b+1'3*>+7')1
?"'7)'=51
-
8/10/2019 CHF/CCM board review
21/46
4A'=/F+'"# "8 D"01=% +#G @%,81&/"#
M7505"1'" n;. `$) o 65+)7 E+*>$)5 W^^^
D+&"G/0+-",&
Mbi
E
L >
=/is
Hen/
;!i-
;`c
6*9( Mbi
Diuretics
-
8/10/2019 CHF/CCM board review
22/46
!+&%
VW ?J"J =+# H_ #"#I/&3;%=/3 !Q@ Y>. KVT[ +G=/g%G H_ H%/$;- $+/# +#GG?&A#%+ G%&A/-% /#3,%+&/#$ ",+0 0""A G/1,%'3&J
>h+=9 *f LV ^@ OMM_VM ff KK c%/$;- OM 05& U O =-; +$"J
iD@ -" +#$0% "8 6+HN 30%+, 01#$&N B"1G @KN ]WN QfN G/&-%#G%G +5G"=%#N
+#G -,+3% A%,/A;%,+0 %G%=+J
B+5&9 *3- WMTN 3 A'$ 7)5+7 7(*1 =+@5"7{
!.
?b n''= /*$)5@41
8.
?b n''= /*$)5@4 | ?b b+1'3*>+7')H. ?b n''= /*$)5@4 | ?b ?"'7)'=5
-
8/10/2019 CHF/CCM board review
23/46
2/1,%&/& /# E2*. n''= 3*$)5@41D ?b C'>$1 ') 4'"@"$'$1 *"2$1*'"
E$)'15:*35, 7')15:*35, C$:57+"*35
?"*@+75 )+=*3>A +7 3'15 } ')+> )59*:5"
g*05 +7 2)5X$5"7 *"75)0+>1
N+&9)B>:#)*: '*>'=)*"B>B '#: ?:'H 9"%#:($B '*9 %B:9 E)B>&< ;)# OP
BD'#"*= '*9 *:%#)Q)#E)*'& :R:$>B n'B5) k>>*"9 =)511$)51 >5+3 7' *:=)'053 '$74':51
obJ v WQ $1$+>>A *:=>*51 JH; v [[ :: 69
!*: 2') obJ v U :: 69
?" ib 2+*>$)5, :+A (+05 7' 15~>5 2') + 1>*9(7>A (*9(5) obJ H':=>*4+@'"1D zpR-9, :57+C'>*4 +>m+>'1*1, zgEi,
""5$)'('):'"+> +4@0+@'", '7'7'I*4*7A
-
8/10/2019 CHF/CCM board review
24/46
24]> :,/+0
&VQU =71 B*7( !/6E, v [a ()1 +3:*11*'"
6?g6 01. ne; /eM` /*$)5@41
x *:=)'05:5"7 *" 3A1="5+ \ P[ ()1
x "57 3*$)51*1 +"3 B5*9(7 >'11 \ P[ ()1
x =)'=')@'" BR ;iE FxH) Y Q.V :9R3nG
&' 3*u *" 35+7(, )5L('1=*7+>*K+@'", ') `/ 0*1*71 \ NQ3
8enjM 01. He&c?&jejM /*$)5@4 ?"2$1*'" &' 3*u5)5"45 *" +"A '$74':51
E5>m5) 57 +>. &`o- [QWW_VNaDP^PLUQS.
Low
Dose
High
Dose
Q12Bolus
Continuous
1X oral
1X oral
2.5X oral
2.5X oral
-
8/10/2019 CHF/CCM board review
25/46
!+&% !"#-GJ
Eg%=A-& +- G/1,%&/& H/-; %&3+0+'#$ G"&%& "8 aD 81,"&%=/G%
YKMM =$ aD 5/G[ 0%+G -" /#3,%+&%G ^j*"5 2') (5:'3A"+:*4 50+>$+@'"
-
8/10/2019 CHF/CCM board review
26/46
-
8/10/2019 CHF/CCM board review
27/46
4(%,3"=/#$ l2/1,%'3 f%&/&-+#3%m
t
6*9( 3'15 3*$)5@41t c(*+K*35 3*$)5@41 7' +$9:5"7 >''= 5u547
t
-57'>+K'"5, /*$)*>
t j>7)+k>7)+@'"
t
&'05> +95"71 7(+7 =)':'75 &+R6[e 5I4)5@'" +73*u5)5"7 =+)71 '2 7(5 "5=()'"D
t
&' C5"5k7 B*7( "51*)*@35, 7'>0+=7+", ') +35"'1*"5+"7+9'"*171 F"'7 +==)'053G
t
?b 0+1'+4@05 +95"71t i5"+> 3'15 3'=+:*"5 ') 0+1'3*>+7')1
-
8/10/2019 CHF/CCM board review
28/46
!Ef>]]9 j. (&J aD 2/1,%'3&
&WUU
M6E ') /6E
} [ 1*9"1 '2 !/6E
"MH) } Q.V, W[ Bm =)*')
7' ') WQ 3 +Z5) +3:*7
&' ?b 0+1'+4@05 :531
MH) v V.S :9R3n
Bart et al. NEJM 2012;367:2269-304
-
8/10/2019 CHF/CCM board review
29/46
D+&"A,%&&/# f%3%A-", E#-+$"#/&-&
H':=+)53 7' =>+45C',
7'>0+=7+" VQ :9R3D
!C'3A B5*9(7 \ W 3
!3A1="5+ \ W +"3 P 3
"15)$: 1'3*$:
"7(*)17, 3)A :'$7(
&' 3*u5)5"45 *" )5"+>2$"4@'"
g(5')9(*+35 57 +>., o!-! [QQP_[^PDWVW^
< Z SOWWN *. +G=/-N BD>. n SMTN R SL; +G=JN ]!, R WJV =$_GB
-
8/10/2019 CHF/CCM board review
30/46
!+&%
;(+7 *1 7(5 :'17 >*m5>A 3*+9"'1*1{
!. !4$75 :A'4+)3*+> *"2+)4@'"
8.
!4$75 :A'4+)3*@1
H. !4$75 =5)*4+)3*@1 B*7( 7+:='"+35
VS A.'. =)50*'$1>A B5>> 25:+>5 BR [ Bm1 '2 =)'9)511*05 3A="5+ "'B \
)517. | 4(517 @9(7"511
`I+:D 6i W[Q, 8J UQRNQ, ii VQ, M+71 ^aT i!. obJ WU 4: 6[e, C*>+75)+>
)+>51, 1$::+@'" 9+>>$=, (5=+7':59+>A, +"3 4''> 5I7)5:*@51 BR W|
535:+.
M7$3*51D M*"$1 7+4( BR 3*u$15 Mc 5>50+@'", 4c"? Q.P
`4('D nb`// WSL[QT, 9>'C+> 6p, nb`// S.S. 4:
-
8/10/2019 CHF/CCM board review
31/46
2%-%,=/#+'"# "8 ^%G&/G%
*%="G?#+=/3 @,"70%
CONGESTION?
ADEQUATE
PERFUSION?
DRY
A B
L C
WET
WARM
COLD
-
8/10/2019 CHF/CCM board review
32/46
!+1&%& "8 !+,G/"$%#/3 ];"3k
E31-% QaJ$:= E+*>$)5
n+)95 *"2+)4@'"
M:+>>5) *"2+)4@'"1 B*7(=)55I*1@"9 H6E
?"2+)4@'" 5I75"1*'" ')
5I=+"1*'"-54(+"*4+> 4':=>*4+@'"1
bM/
!4$75 -i
E)55 ;+>> )$=7$)5
ib *"2+)4@'"
)$=7$)5G
nb '$>'B 'C17)$4@'" F5.9. !M, 6H-G
nb *"l'B 'C17)$4@'" F5.9. :AI':+, -MG!')@4 /*1154@'"
J5)*4+)3*+> c+:='"+35
-+11*05 =$>:'"+)A 5:C'>*1:
`"3LM7+95 H+)3*':A'=+7(A
J)'>'"953 H+)3*'=$>:'"+)A 8A=+11
H+)3*+4 H'"7$1*'"
-
8/10/2019 CHF/CCM board review
33/46
4A'=/F+'"# "8 D"01=% +#G @%,81&/"#
M7505"1'" n;. `$) o 65+)7 E+*>$)5 W^^^
D+&"G/0+-",&
Mbi
E
L >
=/is
Hen/
;!i-
;`c
6*9( Mbi
Diuretics
-
8/10/2019 CHF/CCM board review
34/46
aD D+&"G/0+-",& /# E2*.
&*7)'=)$11*35D
!)75)*+> Y 05"'$1 0+1'3*>+7')
c*7)+75 7' Mbi UQQLW[QQ ') M8J } UQ, B(*4(505) 4':51 k)17
H':=>*4+@'"1D (A='75"1*'", 7(*'4A+"+75 7'I*4*7A
&*7)'9>A45)*"D
b5"'$1 Y +)75)*+> 0+1'3*>+7')
/)$9 '2 4('*45 2') *14(5:*+
H':=>*4+@'"1D (A='75"1*'", (5+3+4(5, 7+4(A=(A>+I*1
&51*)*@35D
b5"'$1 Y +)75)*+> 0+1'3*>+7')
J)':'751 "+7)*$)51*1 +"3 3*$)51*1
H':=>*4+@'"1D (A='75"1*'" F9)5+75) 7(+" B*7( "*7)'9>A45)*"G
-
8/10/2019 CHF/CCM board review
35/46
E]!>)*"'"5 ')3'C$7+:*"5 v S9Rm9R:*"
M*:*>+) '$74':51 +1"*7)'9>A45)*"* No difference in WRF
OConnor et al. NEJM 2011;365:32-43.
-
8/10/2019 CHF/CCM board review
36/46
E31-% !*.I aD a#"-,"A%&
H':=>*4+@'"1D x :A'4+)3*+> 'IA95" 35:+"3, +))(A7(:*+1,"5$)'('):'"+> +4@0+@'"
&' :')7+>*7A C5"5k7 1"*$#:'B:9 $)ED'#:9 >) S'B)9"&'>)#B5 j15 '">A +1 C)*395 7' 35k"*@05 7(5)+=A ') 2') =+>>*+@'" *"
:53*4+>>A )52)+47')A =+@5"71
F/)6 MN O
N O
P QJ >? BRJ IRJ
2"51-+=/#% YKIOM o$_k$_=/# p ppp pp qr rr s q
2"A+=/#%
OIK o$_k$_=/# t t t q q q q
KIOM o$_k$_=/# p pp t r rr qr q
OMIKM o$_k$_=/# ppp pp t rr qr rr q
Q/0,/#"#% YMJOIMJXV o$_k$_=/#[ @2> W /#;/5/-", r rr ss s
-
8/10/2019 CHF/CCM board review
37/46
];",-I-%,= aD Q/0,/#"#% a# *"&A/-+0/F%G
E2*. @+'%#-&9 4@:aQ>I!*.
0
2
4
6
8
10
12
Placebo
Milrinone
T@
+'
%#-&21,/#$*"
&A/-+0/F+'"#
Qa E ./5 D:_D. ^@ 2%+-;H$u5 57 +>. o!-! [QQ[_[UPDWSaWLP.
*
*
-
8/10/2019 CHF/CCM board review
38/46
v1%&'"#
;(+7 7(5)+=A B'$>3 A'$ )54'::5"3{
!.
?b 3*$)5@41
8. ?b 0+1'3*>+7')1
H. ?b *"'7)'=51
/.
! | 8`. ! | H
J7
-
8/10/2019 CHF/CCM board review
39/46
!+&% !"#-GJ
c)5+753 B*7( ?b 3'C$7+:*"5 +"3 2$)'15:*35 B*7(*:=)'05:5"7 *" (5:'3A"+:*41 +"3 H)
!~5:=753 7' B5+" :*>)*"'"5 +"3 7)+"1*@'" 7' ')+>
!H`L? C$7 )*1*"9 4)5+@"*"5 +"3 354)5+1*"9 $)*"5
'$7=$7
E5>7 7' C5 :*>)*"'"5 35=5"35"7 +"3 4'"1*35)53 2')
+30+"453 7(5)+=*51 Fb!/R7)+"1=>+"7G
-
8/10/2019 CHF/CCM board review
40/46
c;" &;"10G 5% 3"#&/G%,%G 8", +G(+#3%G
-;%,+A/%&e
`14+>+@"9 3*$)5@4 3'15 )5X$*)5:5"71
J)'9)511*05 )5"+> 3A12$"4@'"
?"4)5+1*"9 2)5X$5"4A '2 6E ('1=*7+>*K+@'"
?"4)5+1*"9 C$)35" '2 05"7)*4$>+) +))(A7(:*+1
?"7'>5)+"45 '2 17+"3+)3 :53*4+> 7(5)+=A
i52)+47')A 6E 1A:=7':1
&553 2') *"'7)'=*4 1$==')7
Y ST "'"Ll$*3 )5>+753 B5*9(7 >'11 F4+4(5I*+G
J%#'T&: K+JB '#: *)> B'&S'=: >Q:#'D< ;)# '$%>:$'#9")=:*"$ BQ)$H
-
8/10/2019 CHF/CCM board review
41/46
j&% "8 aE^@
H'"1*35) 2')
=+@5"71 B*7( Mc`-? B(5"
4+)3*'95"*4 1('4m *1 "'7
)+=*3>A )505)153 B*7(
=(+):+4'>'9*4 7(5)+=A
*"'7)'=5L)52)+47')A (5+)72+*>$)5 *" =+@5"71 B*7(
4+)3*':A'=+7(A
-53*4+>>A )52)+47')A
05"7)*4$>+) 7+4(A4+)3*+
-54(+"*4+> -? 4':=>*4+@'"FbM/, J+=*>>+)A :$14>5
)$=7$)5G
H'"7)+*"3*4+@'"1
M*9"*k4+"7 !?
M505)5 J!/
!C3':*"+> +')@4 +"5$)A1:
!')@4 /*1154@'"
-
8/10/2019 CHF/CCM board review
42/46
Q%3;+#/3+0 j#0"+G/#$ 8", -;% .+/0/#$ *%+,-9
^%?"#G ^+00""# !"1#-%,A10&+'"#
a=A%00+ KJVN VJM !+,G/+3E&&/&- ]?&-%=
f%-,"$,+G% 3+##10+'"# "8 BD (/+
8%=",+0 +,-%,?
Q/3," Eh/+0 .0"H @1=A
KVMMMIWMMMM ,A=
.0"H KJV ", VJM B_=N G%A%#G/#$
"# G%(/3%
BD &1AA",- "#0?
EAA,"(%G 8", 8+3/0/-+'"# "8 ;/$;I
,/&k @!a
-
8/10/2019 CHF/CCM board review
43/46
Q%3;+#/3+0 j#0"+G/#$ 8", -;% .+/0/#$ *%+,-9
@%,31-+#%"1& E&&/&- 2%(/3%&
:+#G%=*%+,-9a#w"H9 KO. :,+#&&%A-+0 B%C E-,/+0
!+##10+ (/+ 8%=",+0 (%/#
41x0"H 9 OVIOX. .%=",+0 E,-%,?
!%#-,/81$+0 A1=A
Q+h XMMMILMMM ,A=
.0"H SIV B_=
!+# 5% 3"#7$1,%G 8", fD_^/ID
&1AA",- H/-; G/,%3- &1,$/3+03+##10+'"#
a#-%#G%G 8", -%=A",+,? &1AA",-
' ; / 8 8
-
8/10/2019 CHF/CCM board review
44/46
a#&'-1-% :;%,+A/%& 8", :,%+-=%#- "8
!;,"#/3 ]-+$% ! *.
/*$)5@41L z 1A:=7':1
/*9'I*"L z ('1=*7+>*K+@'"1
b+1'3*>+7')1L x 1$)0*0+>
!H` ?"(*C*7')1 F!i81G
6A3)+>+K*"5L"*7)+75 *" !2)*4+" !:5)*4+"1
857+L8>'4m5)1L x 1$)0*0+>
/' "'7 17+)7 B(5" +4$75>A 354':=5"1+753
!>3'175)'"5 +"7+9'"*171L x 1$)0*0+>
`J /50*45 c(5)+=AL x 1$)0*0+>
?H/, Hic
-
8/10/2019 CHF/CCM board review
45/46
:,%+-=%#- I 2/+&-"0/3 !*.
c)5+7 4'"951@'"
H'"7)'> 6c&
c)5+7 *14(5:*+
-+*"7+*" 1*"$1 )(A7(:
H'"7)'> (5+)7 )+75
0'UV%"9 #:B>#"$()*/
9"%#:($B
+*(PQ:*B"S:B
0">#'>:B/ T:>'PT&)$H:#B/!!-/ @!8U!+-W
!'#9")S:#B")* "; +XT
-:>'PT&)$H:#B/ !!-/9"=)Y"*/ +K *)9'&
'T&'()*
-
8/10/2019 CHF/CCM board review
46/46
]1==+,?
6E *1 + 4>*"*4+> 3*+9"'1*1, C$7 8&J :+A C5 $152$> B(5" 7(5)5 *1 3*+9"'1@4
$"45)7+*"7A
c)5+7:5"7 '2 6E 1('$>3 C5 7+)95753 +7 '=@:*K+@'" '2 0'>$:5 17+7$1 B*7(
:+*"75"+"45 '2 +35X$+75 5"3L')9+" =5)2$1*'"
J+@5"71 1('$>3 C5 3*$)5153 7' obJ v WQ 4: 6[e B(5" ='11*C>5 +"3
0+1'3*>+7')1 1('$>3 C5 $153 *" =)525)5"45 7' *"'7)'=51
i'$@"5 *"0+1*05 (5:'3A"+:*4 :'"*7')*"9 'u5)1 "' +30+"7+95 '05)
C531*35 4>*"*4+> +11511:5"7
?"*@+75 >*251+0*"9 7(5)+=*51 =)*') 7' ('1=*7+> 3*14(+)95 +"3 4'')3*"+75
>'"9*7$3*"+> 2'>>'BL$=
J+@5"71 B*7( )52)+47')AR)54$))5"7 1A:=7':1 7(+7 +)5 )51*17+"7 7'17+"3+)3 7(5)+=A 1('$>3 C5 )525))53 2') 4'"1*35)+@'" '2 +30+"453
7(5)+=*51